What is Hepatitis B?
Hepatitis B Virus Cure in India 2021 is an inflammation of the liver caused by the hepatitis B virus. People who become infected with the virus in childhood have a very high chance (> 80%) of carrying the virus for the rest of their lives and some of them end up with cirrhosis, liver failure, and liver cancer. These people have no symptoms until the disease is in the advanced stage.
When an adult becomes infected with hepatitis B, he or she usually has severe hepatitis with symptoms such as fever and jaundice, and only a few develop into chronic and severe hepatitis.
Worldwide, some 350 million people have chronic hepatitis B and 1 million die from hepatitis B-related illnesses each year.
What should you know to keep others from getting HBV?
All people living with you should get a hepatitis B vaccine.
Do not share anything that may contain blood, such as a toothbrush or a razor blade.
Do not donate your blood, organs, other tissues.
Close your cuts and open sores.
Is there a cure for Hepatitis B?
If you have hepatitis B you should see a liver specialist who will order a blood test to see if you have any minor or severe liver damage and the level of the virus in your blood. This will determine if you should be treated. Some people with chronic hepatitis B may need antiretroviral drugs to suppress the virus and prevent damage to their liver.
Approved treatments for hepatitis B include Interferon, Lamivudine, Telbivudine, Adefovir, Tenofovir, and/or Entecavir.
Treatment of HBV in India
HOO-IMM PLUS anti-virus treatment in patients with severe and incurable Hepatitis B disease focuses on preventing the spread of the virus and prevents DNA Polymerase from HBV blood in combination with many other HBV targ drugs that can prevent re-infection and protect life Liver cells -hepatocyte opens up new natural treatment options without the side effects of people infected with HBV.
HBV Treatment Failed:
There are many anti-viral drugs currently available for HBV treatment including IFN alpha, Lamuvidine, Entecavir, Telbibudine, and Tenofovir.
Interferon treatment has limited effectiveness, low performance, and often creates side effects.
Common side effects include fever, pain, diarrhea, vomiting, feelings of depression, rash, insomnia.
HOO-IMM PLUS, an herbal formula confirms the effectiveness of many HBV anti, Hepatocellular Carcinoma (HCC), and Hepatoprotective agents.
Anti – HBV
The work of HOO-IMM PLUS HBV has been reported by many Ayush healers in India and by pharmacists from Africa. HOO-IMM PLUS has been widely studied in the treatment of Hepatitis B Virus by inhibiting HBsAg cell secretion PLC / PRF / 5 and preventing Hepato carcinoma in the HepG2 cell line.
In medical patients receiving Hooimm and Target reported it is not available in the Hepatitis B DNA Quantitative.
Chemopreventive HOO-IMM PLUS – Anti-Hepatocellular Carcinoma (HCC)
The HOO-IMM PLUS forms a curcumin molecule that has been proven to be a key astrological factor in the prevention of hepatocellular carcinoma. Many studies have been done with curcumin suggesting that it prevents the progression of apoptosis, which can reduce ROS.
Here we have a different Curcuma longa extract system that produces curcumin with a higher level of availability and other herbal extracts that improve intestinal curcumin absorption.
Hooimm Plus prevents liver damage in viral hepatitis. People with HBV who receive Hooimm and treatment have a normal liver enzyme. The treatment prediction reports a randomized trial of Serum Alanine Aminotransferase (ALT) or serum glutamic pyruvic transaminase (SGPT) and Aspartate Aminotransferase (AST).
AST and SGPT are blood tests for liver damage.
Biomarker or Protocol Protocol involved in anti-HBV treatment with Hooimm plus: –
Symptoms of HBV Serological include HBsAg & HBeAg Elisa.
Serum Alanine Aminotransferase (ALT) or Serum glutamic pyruvic transaminase (SGPT) and Aspartate Aminotransferase (AST) or SGOT.
The burden of HBV DNA Quantification-Viral Load.
Note: Quantification for HBV DNA indicates viral load which plays a very important role in determining the stage of infection, determining treatment, and finding the response to viral treatment.
This test is highly recommended in the Chronic HBV- World Health Organization (WHO)
hepatitis b treatment, HBV treatment, HBV treatment, hoo-imm plus
Hoo-Imm Plus With Hootone Solutions
Glycyrrhizin, a major component of the drug (licorice), has been widely used to treat chronic hepatitis B in Japan.
Its effects on the secretion of hepatitis B surface antigen (HBsAg) were tested in vitro. Glycyrrhizin suppressed the HBsAg fluid and accumulated it in amounts in PLC / PRF / 5 cells.
The aqueous extraction of the plant Phyllanthus niruri inhibits the chronic DNA polymerase of the hepatitis B virus and binds to the surface of the hepatitis B antigen virus in vitro.
The potential anti-HBV agent, ellagic acid, was isolated from the plant drug P. niruri, and its natural properties.
Phyllanthus niruri (Bhumyamalaki) had the ability to inhibit HBV polymerase by reducing episomal HBV DNA content by reducing HBV messenger RNA transcription.
In silico analysis of strong chemicals from Terminalia chebula have been shown to be effective in fighting the Hepatitis B virus.
In the HBs antigen-binding assay, the ethnicized ethanolic extraction of Terminalia Cheb showed a high inhibition of 60% and aqueous extraction showed a 55% inhibition and the administration of lamivudine showed a 60% inhibition.
Curcumin treatment has led to a reduction in dose and time and dosage in HBsAg and HB
Failed Tenofovir Treatment
Several anti-viral those are currently available for the treatment of HBV which
includes IFN alpha, Lamuvidine, Entecavir, Telbibudine and Tenofovir.
Interferon therapy has limited efficacy, slow-acting, and frequently causes adverse
malaise, fatigue, depression, hair loss, neutropenia, and thrombocytopenia.
On the other hand, the side effects of Tenofovir are no less than Interferon. The
common side effects include fever, pain, diarrhea, vomiting,
rashes, insomnia. Moreover, the anti-viral drug and Interferon are expensive.
Moreover, if the patient drops the Tenofovir medication even for 48 hours the
HBV viral load elevates to 10 3 .
HBV DNA Quantitative
Quantification of HBV DNA reflects the viral load which plays a critical role in
determining the phase of infection, deciding the treatment, and determining the
response to anti-viral treatment.
Case 1: Patient dropped Tenofovir
In this present study, HBV patients receiving conventional Tenofovir had to drop
the treatment due to poor compliance (developing jaundice within the interval of
15 days and incidence of elevated SGPT & SGOT level) after cessation of Tenofovir therapy.
The patients discontinued the Tenofovir
therapy due to side effects and went on HOO-IMM PLUS therapy. for Hepatitis B Virus Cure in India 2021
After the cessation of Tenofovir therapy for 21 days, the mean HBV DNA level
was 5.7 log IU/ml. With the follow up of HOO-IMM PLUS treatment in the first
the mean HBV DNA level was 3.5 log IU/ml and the treatment was
continued for 12 months reported Target Not Detected for HBV DNA
Case 2: Drug naïve HBV individual receiving HOO-IMM PLUS
In this present study, the patient never had any medication pertaining to HBV
infection, received HOO-IMM PLUS therapy, they showed good compliance and
virological suppressions right after few weeks of treatment. The patients
declined to mean 3.7 log IU/ml in the first 4 months of the treatment to mean 1.46
log IU/ml in the next 4 months of the treatment
followed by Target Not Detected
in the 12th month monitoring. Moreover,
throughout the treatment, of Hepatitis B Virus Cure in India 2021.
Normal Liver Function
Hooimm Plus prevents liver injury from viral hepatitis. HBV individuals
receiving Hooimm plus treatment having normalized liver enzyme. The treatment
prognosis reports a normal level of the routine test of Serum Alanine
Aminotransferase (ALT) or Serum glutamic pyruvic transaminase (SGPT) and
Aspartate Aminotransferase (AST). AST and SGPT is a blood test that checks for
the liver damage.
Biomarker or Test protocol involved in the anti-hbv treatment with Hooimm
- HBV Serological markers which include HBsAg & HBeAg Elisa.
- Serum Alanine Aminotransferase (ALT) or Serum glutamic pyruvic
transaminase (SGPT) & Aspartate Aminotransferase (AST) or SGOT.
- HBV DNA Quantification-Viral Load.
Preventing viral-induced Carcinoma
The HOO-IMM PLUS constitutes a curcumin molecule that has been proven a
star key molecule in preventing hepatocellular carcinoma.
the obstacle for its efficacy. Here we have a unique extraction procedure for Curcuma
longa which yields curcumin with high degree bioavailability and along with
other herbal extract formulation that improves the gut absorption of curcumin.